ALBANY — While states have been in the forefront of legal marijuana expansion, the banking industry in New York and elsewhere is still shy about collecting revenue from a Schedule I substance that’s still illegal at the federal level.

Banking is a major hurdle for the legal medical marijuana business, lawyers say. Big banks are reluctant to get involved because of the uncertainty around federal anti-money laundering and other statutes aimed at discouraging moving illegal cash around.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]